Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Top-line data from the CLARITY-Gastric01 study showed sonesitatug vedotin significantly extended overall survival in patients who had received at least two prior lines of therapy and also met a key secondary endpoint in an earlier-line population, although the trial failed to achieve statistical significance for progression-free survival
The value of biological aging tests, and why physical performance remains the most reliable marker [2:30]
doi: 10.3390/nu13020699 239 SuzukiTMiyakiKTsutsumiAHashimotoHKawakamiNTakahashiMet al
(2) Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D
GSE77722, RNA-seq of murine in vivo reprogramming in mice of varying genotypes
US$ 23.71
US$ 25.11
US$ 21.87
US$ 20.29
US$ 29.19
